Liabilities / Assets
12th percentile
Higher debt load relative to assets than 12% of similar nonprofits.
990 • Fiscal year 2014 • EIN 46-0481876
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
12th percentile
Higher debt load relative to assets than 12% of similar nonprofits.
Liabilities / Revenue
17th percentile
Higher debt load relative to revenue than 17% of similar nonprofits.
Net Margin
95th percentile
Higher net margin than 95% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
85th percentile
Faster asset growth than 85% of similar nonprofits.
Revenue Growth
93rd percentile
Faster revenue growth than 93% of similar nonprofits.
Assets
Up$31,553,912
Up $4,905,954 (+18%) from 2013
Net Assets
Up$31,088,615
Up $4,763,639 (+18%) from 2013
Liabilities
Up$465,297
Up $142,315 (+44%) from 2013
Revenue
$5,921,552
No earlier filing loaded for comparison.
Expenses
Down$1,989,408
Down $50,743 (-2.5%) from 2013
Net Income
$3,932,144
No earlier filing loaded for comparison.
This 2014 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The biotechnology greenhouse of southeastern pennsylvania was established with funds from the commonwealth of pennsylvania's share of the national tobacco settlement to accelerate growth of the life sciences industry by transforming the southeast pennsylvania region's strength in biomedical research and development into commercial opportunities. Approximately $25 million of the original government grant funding has been dedicated for pre-seed or "gap" funding for promising therapeutic, biomedical device and related technology companies, in a program called the greenhouse fund. The greenhouse fund is designed to move promising scientific projects out of the laboratory and into commercial opportunities. Additional funds were set aside for initiatives to increase the region's strengths in biomedical informatics and clinical trials.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2014 • Form 990Summary only. Only limited summary data is available for this year.
Similar nonprofits based on the same Siviq industry and scale cohort. 2014 filings • 501(c)3 • $25M-$50M nonprofits
Richmond, VA
View Organization501(c)3
Revenue vs current organization
154% higherAssets vs current organization
About the sameBaton Rouge, LA
View Organization501(c)3
Revenue vs current organization
432% higherAssets vs current organization
100% lowerPortland, OR
View Organization501(c)3
Revenue vs current organization
297% higherAssets vs current organization
About the sameSan Bernardino, CA
View Organization501(c)3
Revenue vs current organization
33% higherAssets vs current organization
About the same